The use of incretins and fractures - a meta-analysis on population-based real life data

Johanna H. M. Driessen, Frank de Vries*, Hein van Onzenoort, Nicholas C. Harvey, Cees Neef, Joop P. W. van den Bergh, Peter Vestergaard, Ronald M. A. Henry

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)923-926
Number of pages4
JournalBritish Journal of Clinical Pharmacology
Volume83
Issue number4
DOIs
Publication statusPublished - Apr 2017

Keywords

  • dipeptidyl peptidase 4-inhibitors
  • fracture
  • glucagon-like peptide 1-receptor agonists
  • incretin agents
  • meta-analysis
  • PEPTIDE-1 RECEPTOR AGONISTS
  • DIPEPTIDYL PEPTIDASE-4 INHIBITORS
  • RANDOMIZED CLINICAL-TRIALS
  • ANTI-HYPERGLYCEMIC DRUGS
  • BONE-FRACTURES
  • RISK

Cite this